Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy

Medical Clinics of North America

Volumn 82, Issue 3, 1998, Pages 635-658

  Walenga, J M ^a   Bick, R L ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANCROD; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ARGATROBAN; DALTEPARIN; DANAPAROID; DEXTRAN; FIBRINOLYTIC AGENT; HEPARIN; HIRUDIN; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

CLINICAL FEATURE; DRUG INDUCED DISEASE; HEMATOLOGIC DISEASE; HUMAN; HYPERSENSITIVITY; LABORATORY TEST; OSTEOPOROSIS; PATHOGENESIS; PLASMAPHERESIS; PREGNANCY; PRIORITY JOURNAL; RASH; REVIEW; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 0031750556     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70015-8     Document Type: Article

References (79)

1. V. Abhyankar P. Kouides P. Phatak Heparin-induced thrombocytopenia is a cause of thromboembolism following coronary by-pass surgery Blood 86 suppl 1 1995 846a
2. A. Altés M. Rodrigo M. Gari Heparin-induced thrombocytopenia and heart operation: Management with tedelparin Ann Thorac Surg 59 1995 508
3. J. Amiral F. Bridey M. Dreyfus Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia Thromb Haemost 68 1992 95
4. R.H. Aster Heparin-induced thrombocytopenia and thrombosis N Engl J Med 332 1995 1374
5. L.A. Barbour S.D. Kick J.F. Steiner A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry Am J Obstet Gynecol 170 1994 862 869
6. A.J. Bircher P.H. Itin S.A. Buchner Skin lesions, hypereosinophilia and subcutaneous heparin [letter] N Engl J Med 343 1994 861
7. J.T. Brandt C.E. Isenhart J.M. Osborne On the role of platelet FcRIIA phenotype in heparin induced thrombocytopenia Thromb Haemost 74 1995 1564
8. J.R. Chamberlin B. Lewis F. Leya Successful treatment of heparin-associated thrombocytopenia and thrombosis using hirulog Can J Cardiol 11 1995 511
9. Chigot P. De Gennes C. M.M. Samama Osteoporosis induced either by unfractionated heparin or by low molecular weight heparin J Mal Vasc 21 1996 121 125
10. B.H. Chong J. Burgess F. Ismail The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia Thromb Haemost 69 1993 344
11. B.H. Chong F. Ismail J. Cade Heparin-induced thrombocytopenia: Studies with a new low molecular weight heparinoid, Org 10172 Blood 73 1989 1592
12. D.B. Cines A. Tomaski S. Tannenbaum Immune endothelial-cell injury in heparin associated thrombocytopenia N Engl J Med 316 1987 581
13. J.I. Cohen M.R. Cooper C.S. Greenberg Streptokinase therapy of pulmonary emboli with heparin-associated thrombocytopenia Arch Intern Med 135 1985 1725 1726
14. C.W. Cole J. Bormanis Ancrod: A practical alternative to heparin J Vasc Surg 8 1988 59
15. T.C. Dahlman Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin Am J Obstet Gynecol 168 1993 1265 1270
16. C. Demers J.S. Ginsberg P. Brill-Edwards Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia Blood 78 1991 2194
17. J. Douketis J.S. Ginsberg R.F. Burrows The effects of long-term heparin therapy during pregnancy on bone density: A prospective matched cohort study Thromb Haemost 75 1996 254 257
18. S. Eichinger P.A. Kyrle B. Brenner Thrombocytopenia associated with low-molecular-weight heparin Lancet 337 1991 1425
19. J. Fareed W. Jeske J.M. Walenga An antiplatelet drug, ticlopidine, inhibits heparin-induced thrombocytopenia (HIT) responses as measured by platelet aggregometry and 14C serotonin release J Am Coll Cardiol 29 suppl A 1997 66A
20. J.N. Fiessinger M. Aiach M. Roncato Critical ischemia during heparin-induced thrombocytopenia: Treatment by intra-arterial streptokinase Thromb Res 33 1984 235
21. R. Giustolisi P. Guglielmo di Raimondo F. Hypereosinophilia and subcutaneous heparin [letter] N Engl J Med 342 1993 1371
22. M. Gouault-Heilmann D. Payen G. Contant Thrombocytopenia related to synthetic heparin analogue therapy Thromb Haemost 54 1985 557
23. A. Greinacher T. Eckhardt J. Mussman Pregnancy complicated by heparin associated thrombocytopenia management by a prospective in vitro selected heparinoid (ORG 10172) Thromb Res 71 1993 123
24. A. Greinacher M. Feigl C. Mueller-Eckhardt Crossreactivity studies between sera of patients with heparin associated thrombocytopenia and a new low molecular weight heparin, reviparin Thromb Haemost 72 1994 644
25. A. Greinacher I. Michels U. Liebenhoff Heparin-associated thrombocytopenia: Immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharides Br J Haematol 84 1993 711
26. A. Greinacher B. Pötzsch J. Amiral Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multi-molecular PF-4 heparin complex as the major antigen Thromb Haemost 71 1994 247
27. J. Hirsh R. Raschke T.E. Warkentin Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety Chest 108 1995 258 275S
28. S.G. Howe D.M. Lynch An enzyme-linked immunosorbent assay for the evaluation of thrombocytopenia induced by heparin J Lab Clin Med 105 1985 554
29. B.J. Hunt H. Doughty G. Majumdar Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies Thromb Haemost 77 1997 39 43
30. C.V. Hussey V.N. Bernhard M. McLean Heparin induced platelet aggregation: In vitro confirmation of thrombotic complications Ann Clin Lab Sci 9 1979 487
31. Jeske W.P. Walenga J.M. Szatkowski E. Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets Thromb Res 1988 in press
32. J.R. Kappa C.A. Fisher H.D. Berkowitz Heparin-induced platelet activation in sixteen surgical patients: Diagnosis and management J Thorac Cardiovas Surg 5 1987 101
33. J.R. Kappa C.A. Fisher B. Todd Intraoperative management of patients with heparin-induced thrombocytopenia Ann Thorac Surg 49 1990 714
34. R.A. Kelly J.A. Gelfand S.H. Pincus Cutaneous necrosis caused by systemically administered heparin JAMA 246 1981 1582 1583
35. J.G. Kelton J.W. Smith T.E. Warkentin Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4 Blood 83 1994 3232
36. J.G. Kelton T.E. Warkentin Diagnosis of heparin-induced thrombocytopenia: Still a journey, not yet a destination [edit] Am J Clin Pathol 104 1995 611
37. P.D. Kumar Heparin-induced skin necrosis N Engl J Med 336 1997 588
38. J. Leroy M.H. LeClerc B. Delahousse Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216) Semin Thromb Hemost 11 1985 326
39. L.E. Levine J.E. Bernstein K. Soltani Heparin-induced cutaneous necrosis unrelated to injection sites: A sign of potentially lethal complications Arch Dermatol 119 1983 400 403
40. B.E. Lewis J.J. Ferguson E.D. Grassman Successful coronary interventions performed with argatroban anticoagulation in patients with heparin-induced thrombocytopenia and thrombosis syndrome J Invas Cardiol 8 1996 110
41. B.E. Lewis F.S. Leya D. Wallis Failure of ancrod in the treatment of heparin-induced arterial thrombosis Can J Cardiol 10 1994 559
42. B.E. Lewis R.C. Rao J.A. Robinson Early plasmapheresis reduces mortality in patients with heparin-induced thrombosis Blood 86 suppl 1 1995 919a
43. B.E. Lewis J.M. Walenga D.E. Wallis Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome Semin Thromb Hemost 23 1997 197
44. H.N. Magnani Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with orgaran (Org 10172) Thromb Haemost 70 1993 554
45. Majerus P.W. Broze G.J. Jr J.P. Miletich Anticoagulant, thrombolytic and antiplatelet drugs Goodman L.S. Gilman A. Rall T.W. The Pharmacological Basis of Therapeutics ed 8 1990 Pergamon Press New York 1311
46. S. Massonnet-Castel E. Pelissier G. Dreyfus Low-molecular-weight heparin in extracorporeal circulation Lancet 8387 1984 1182
47. H.L. Messmore G. Upadhyay S. Farid Heparin-induced thrombocytopenia and thrombosis in cardiovascular surgery Pifarré R. New Anticoagulants for the Cardiovascular Patient 1993 Hanley & Belfus Philadelphia 83
48. P. Moberg V. Geary M. Sheikh Heparin-induced thrombocytopenia: A possible complication of heparin-coated pulmonary artery catheters J Cardiothorac Anesth 4 1990 266
49. M. Monreal E. Lafoz A. Olive Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin Thromb Haemost 71 1994 7 11
50. J.M. Muir M. Andrew J. Hirsh Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo Blood 88 1996 1314 1320
51. J.M. Muir J. Hirsh J.I. Weitz A histomorphometric comparison of the effects of heparin and low-molecular-weight heparin on cancellous bone in rats Blood 89 1997 3236 3242
52. W.J. Murray V.S. Lindo V.V. Kakkar Long-term administration of heparin and heparin fractions and osteoporosis in experimental animals Blood Coagul Fibrinolysis 6 1995 113 118
53. S. Nand J. Robinson Plasmapheresis in the management of heparin associated thrombocytopenia with thrombosis Am J Hematol 28 1988 204
54. T.L. Ortel J.P. Gocherman R.M. Califf Parenteral anticoagulation with the heparinoid Lomoparan (ORG 10172) in patients with heparin-induced thrombocytopenia and thrombosis Thromb Haemost 67 1992 292
55. F.S. Panagakos J.J. Jandinski L. Feder Heparin fails to potentiate the effects of IL-1 beta-mediated bone resorption of fetal rat long bones in vitro Biochimie 77 1995 915 918
56. M. Raible J.M. Walenga B.E. Lewis Plasmapheresis successfully removes heparin-platelet factor 4 antibodies from patients with heparin-induced thrombocytopenia Blood 86 suppl 1 1995 906a
57. M.D. Raible H. Wolf F. Leya Post-PTCA generation of hep-PF4 antibodies is associated with previous exposure to unfractionated heparin: Studies with the chronic administration of LMWH Blood 86 suppl 1 1995 551a
58. R.C. Rao B.E. Lewis S.A. Johnson Thrombolytic experience for treatment of thrombosis in patients with postoperative heparin-induced thrombocytopenia Blood 86 suppl 1 1995 551a
59. D. Robitaille J.R. Leclerc R. Laberge Cardiopulmonary bypass with a low-molecular-weight heparin fraction (enoxaparin) in a patient with a history of heparin-associated thrombocytopenia J Thorac Cardiovasc Surg 103 1992 597
60. F. Rongioletti S. Pisani M. Ciaccio Skin necrosis due to intravenous heparin Dermatologia 178 1989 47 50
61. J.H. Roussi L.L. Houbouyan A.F. Goguel Use of low-molecular-weight heparin in heparin-induced thrombocytopenia with thrombotic complications Lancet 1 8387 1984 1183
62. M.M. Samama L. Bara I. Gouin-Thibault New data on the pharmacology of heparin and low molecular weight heparins Drugs 52 suppl 7 1996 8 15
63. A. Saraux F. Bourgeais A. Ehrhart Osteoporosis during pregnancy: 4 cases Revue du Rhumatisme (Ed Francaise) 60 1993 600 596
64. S.G. Shaughnessy E. Young P. Deschamps The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria Blood 86 1995 1368 1373
65. J. Shefras R.G. Farquharson Bone density studies in pregnant women receiving heparin Eur J Obstet Gynecol Reprod Biol 65 1996 171 174
66. M. Sivakumaran K. Ghosh Y. Zaidi Osteoporosis and vertebral collapse following low-dose, low molecular weight heparin therapy in a young patient Clin Lab Haematol 18 1996 55 57
67. R. Smith N.A. Athanasou S.J. Ostlere Pregnancy-associated osteoporosis QJM 88 1995 865 878
68. M.W. Stewart W.S. Etches L.K. Boshkov Heparin-induced thrombocytopenia: An improved method of detection based on lumi-aggregometry Br J Haematol 91 1995 173
69. van der Wiel H.E. P. Lips P.C. Huijgens Effects of short-term low-dose heparin administration on biochemical parameters of bone turnover Bone Mineral 22 1993 27 32
70. G.P. Visentin S.E. Ford J.P. Scott Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells J Clin Invest 93 1995 81
71. Walenga JM: Relevance of current laboratory methods to the clinical outcome of heparin-induced thrombocytopenia. Presented at the XVIth Congress of the International Society on Thrombosis and Haemostasis Satellite Symposium: Argatroban: A Novel Antithrombotic Drug for the Treatment of Heparin-Induced Thrombocytopenia, Florence, Italy, June 1997
72. J.M. Walenga W. Jeske D. Hoppensteadt Glycoprotein IIb/IIIa inhibitors can prevent heparin mediated platelet activation in heparin-induced thrombocytopenia Haemostasis 26 1996 562
73. J.M. Walenga M.J. Koza B.E. Lewis Relative heparin induced thrombocytopenic potential of low molecular weight heparins and new antithrombotic agents Clin Appl Thromb Hemost 2 suppl 1 1996 S21
74. D.E. Wallis B.E. Lewis R. Pifarré Active surveillance for heparin-induced thrombocytopenia or thromboembolism Chest 106 1994 120S
75. T.E. Warkentin C.P. Hayward C.K. Boshkov Sera from patients with heparin-induced thrombocytopenia generate platelet derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin induced thrombocytopenia Blood 84 1994 3691
76. T.E. Warkentin J.G. Kelton Heparin and platelets Hematol Oncol Clin North Am 4 1990 243
77. T.E. Warkentin M.N. Levine J. Hirsh Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 1995 1330
78. T.E. Warkentin R.L. Soutar A. Panju Acute systemic reactions to intravenous bolus heparin therapy: Characterization and relationship to heparin-induced thrombocytopenia [abstr] Blood 80 suppl I 1992 160a
79. R.E. Weismann R.W. Tobin Arterial embolism occurring in systemic heparin therapy Arch Surg 76 1958 219